Detail akcie Clearmind Medcn Rg online

Business Summary: Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Financial Summary: BRIEF: For the three months ended 31 January 2026, Clearmind Medicine Inc revenues was not reported. Net loss increased from $1.1M to $3.9M. Higher net loss reflects General and Administrative increase from $1M to $3M (expense), Changes in fair value of short-term inve increase from $72K to $573K (expense), Research and development increase of 39% to $640K (expense).